Shorena Janelidze
11 – 20 of 186
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Soluble cerebral Aβ protofibrils link Aβ plaque pathology to changes in CSF Aβ42/Aβ40 ratios, neurofilament light and tau in Alzheimer’s disease model mice
(
- Contribution to journal › Article
-
Mark
The impact of disease activity and interferon-α on the nervous system in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
CSF markers of neuroinflammation, synaptic dysfunction and [18F]DOPA-PET in Parkinson's disease
(
- Contribution to journal › Article
- 2024
-
Mark
Cerebrovascular disease is associated with Alzheimer's plasma biomarker concentrations in adults with Down syndrome
(
- Contribution to journal › Article
-
Mark
Plasma Phosphorylated Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation in People Without Cognitive Impairment
(
- Contribution to journal › Article
-
Mark
Plasma neurofilament light outperforms glial fibrillary acidic protein in differentiating behavioural variant frontotemporal dementia from primary psychiatric disorders
(
- Contribution to journal › Article
-
Mark
MRI-Derived AD Signature of Cortical Thinning and Plasma P-Tau217 for Predicting Alzheimer Dementia Among Community-Dwelling Older Adults
(
- Contribution to journal › Article
-
Mark
Free Recall Outperforms Story Recall in Associations with Plasma Biomarkers in Preclinical Alzheimer Disease
(
- Contribution to journal › Article
-
Mark
Associations between misfolded alpha-synuclein aggregates and Alzheimer's disease pathology in vivo
(
- Contribution to journal › Article